These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7847865

  • 1. Apolipoprotein E genotypes in Parkinson's disease with and without dementia.
    Koller WC, Glatt SL, Hubble JP, Paolo A, Tröster AI, Handler MS, Horvat RT, Martin C, Schmidt K, Karst A.
    Ann Neurol; 1995 Feb; 37(2):242-5. PubMed ID: 7847865
    [Abstract] [Full Text] [Related]

  • 2. [Assessment of apolipoprotein E genotype in Parkinson disease patients with and without dementia].
    Jasińska-Myga B, Opala G, Ochudło S, Tustanowski J.
    Wiad Lek; 2004 Feb; 57(1-2):20-4. PubMed ID: 15181744
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
    Camicioli R, Rajput A, Rajput M, Reece C, Payami H, Hao C, Rajput A.
    Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
    [Abstract] [Full Text] [Related]

  • 4. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
    Parsian A, Racette B, Goldsmith LJ, Perlmutter JS.
    Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
    [Abstract] [Full Text] [Related]

  • 5. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM.
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [Abstract] [Full Text] [Related]

  • 6. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.
    Zareparsi S, Kaye J, Camicioli R, Grimslid H, Oken B, Litt M, Nutt J, Bird T, Schellenberg G, Payami H.
    Ann Neurol; 1997 Oct; 42(4):655-8. PubMed ID: 9382478
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
    Feldman B, Chapman J, Korczyn AD.
    Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.
    de la Fuente-Fernández R, Núñez MA, López E.
    Clin Neuropharmacol; 1999 Jan; 22(4):226-30. PubMed ID: 10442253
    [Abstract] [Full Text] [Related]

  • 13. A pilot study of risk factors for dementia in Parkinson's disease.
    Marder K, Flood P, Cote L, Mayeux R.
    Mov Disord; 1990 Jan; 5(2):156-61. PubMed ID: 2325678
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
    Blázquez L, Otaegui D, Sáenz A, Paisán-Ruiz C, Emparanza JI, Ruiz-Martinez J, Moreno F, Martí-Massó JF, López de Munain A.
    Neurosci Lett; 2006 Oct 09; 406(3):235-9. PubMed ID: 16904828
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dementia in Thai patients with Parkinson's disease: analysis of 132 patients.
    Poungvarin N, Prayoonwiwat N, Devahastin V, Viriyavejakul A.
    J Med Assoc Thai; 1996 May 09; 79(5):278-84. PubMed ID: 8708518
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.